[CIS PIDD] [cis-pidd] BMT for CGD
Prof. Dr. Antonio Condino Neto
condino at icb.usp.br
Wed Feb 20 17:14:50 EST 2013
I have several patients like this one
All long term survivers went to BMT. The others have died, most of
them due to pulmonary complications, infections and /or inflammation
--
Antonio Condino-Neto
Professor of Experimental Medicine
Institute of Biomedical Sciences, University of São Paulo
1730 Lineu Prestes Avenue, São Paulo - SP. ZIP 05508-000. Brazil
Tel (55) (11) 3091-7387 / Fax (55) (11) 3091-7224
Citando "Infante, Anthony J" <INFANTEA at uthscsa.edu>:
> I'm following a 17 year old young man with x-linked CGD, confirmed
> in infancy by both phenotypic NBT carrier analysis and NOX2 genetic
> mutation. He has been on prophylaxis with interferon-gamma,
> trimethoprim-sulfa and itraconazole for many years. His last major
> infection involved multiple abscesses of left axillary lymph nodes
> and skin from axilla to elbow by Nocardia at the age of 5-6 years
> which took about a year to fully resolve despite sensitivity to
> ampicillin. Since that time he has had an occasional skin abscess.
> He has two HLA-matched siblings. His parents have consistently
> refused to seriously consider hematopoietic stem cell
> transplantation because of the peri-transplant risks and the opinion
> that his disease is medically manageable. On a recent routine clinic
> visit, the patient announced his intention to request HSCT upon
> achieving emancipation at age 18 because he is tired of taking
> medications. Your replies should address both the art and science of
> medicine!
>
> Anthony J. Infante, MD, PhD
> Professor, Department of Pediatrics
> Associate Chairman for Research & Academic Affairs
> Chief, Division of Immunology & Infectious Diseases
> University of Texas Health Science Center at San Antonio
> 7703 Floyd Curl Drive MC7802
> San Antonio, TX 78229-3900
> infantea at uthscsa.edu<mailto:infantea at uthscsa.edu>
> tel.210-567-0510
> fax 210-567-6305
> Admin. asst. Stella Wise 210-567-5250
> ______________________________________________________________________________________________________________________________________________________________________________________
> The information in this e-mail may be confidential. This e-mail is
> intended to be reviewed only by the individual or organization named
> above. If you are not the intended recipient or an authorized
> representative of the intended recipient, you are hereby notified
> that any review, dissemination, or copying of this e-mail and its
> attachments, if any, or the information contained herein is
> prohibited. If you have received this e-mail in error, please
> immediately notify the sender by return e-mail and delete this
> e-mail from your system. Thank you.
>
>
> ---
> The CIS-PIDD listserv is supported by the Clinical Immunology Society
> The science & practice of human immunology
>
> P: +1.414.224.8095
> E: info at clinimmsoc.org
>
> Not a member of CIS? Please visit www.clinimmsoc.org to join!
>
> You are currently subscribed to cis-pidd as: condino at icb.usp.br.
> To unsubscribe click here:
> http://lm.clinimmsoc.org/u?id=183824434.e0eda70f3181c972cc892143d303a957&n=T&l=cis-pidd&o=42801926
> or send a blank email to
> leave-42801926-183824434.e0eda70f3181c972cc892143d303a957 at lists.clinimmsoc.org
----------------------------------------------------------------
This message was sent using IMP, the Internet Messaging Program.
--
This email was sent by icb.usp.br
---
The CIS-PIDD listserv is supported by the Clinical Immunology Society
The science & practice of human immunology
P: +1.414.224.8095
E: info at clinimmsoc.org
Not a member of CIS? Please visit www.clinimmsoc.org to join!
You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://lm.clinimmsoc.org/u?id=183939985.3ea13d40a15475ac00ebbd9cd8a37d6d&n=T&l=cis-pidd&o=42802134
or send a blank email to leave-42802134-183939985.3ea13d40a15475ac00ebbd9cd8a37d6d at lists.clinimmsoc.org
More information about the PAGID
mailing list